SCHEMBL20839359

SCHEMBL20839359

C[C@H](C=O)Oc1ccc2c(-c3ccc(F)cc3Cl)cc(=O)oc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.45
▸ HPGD P15428 7/20 0.45
▸ KDM4E B2RXH2 6/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ RECQL P46063 2/20 0.43
▸ IGLV6-57 P01721 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ALDH2 P05091 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839145 0.85 ALDH1A1 (0.64) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL30762931 0.85 ALDH1A1 (0.64) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL20848064 0.85 ALDH1A1 (0.64) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL30231474 0.83 ALDH2 (0.61) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL30762862 0.82 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL20847991 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL30762863 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL20839167 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL20839326 0.82 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10RECQL
SCHEMBL30360979 0.82 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684762-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER Lead Discovery Center GmbH (DE) 2020-07-29 — — EP claimed
WO-2019057821-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2019-03-28 — — WO claimed
EP-3684762-B1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2023-05-03 — — EP disclosed
EP-3684762-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER Lead Discovery Center GmbH (DE) 2020-07-29 — — EP disclosed
WO-2019057821-A1 COUMARIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF FOR THE TREATMENT OF CANCER LEAD DISCOVERY CENTER GMBH (DE) 2019-03-28 — — WO disclosed
Send feedback